|
|
||||||||
Depts of 1 Medicine and 2 Pathology, University of Washington, Seattle, WA, USA. 3 Dept of Pathology, Chung Shan Medical and Dental University, Taichung, Taiwan
CORRESPONDENCE: W.R. Henderson Jr, Dept of Medicine, Box 356523, University of Washington, 1959 NE Pacific Street, Seattle, WA 98195-6523, USA. Fax: 1 2066859318. E-mail: joangb@u.washington.edu
Keywords: Allergy, eosinophils, extracellular matrix, fibrosis, inflammation
Received: February 5, 2003
Accepted February 7, 2004
This study was supported by National Institutes of Health (Bethesda, MD, USA) grants AI42989 and HL73722.
Lung expression of the extracellular matrix protein, laminin, and its receptor, laminin-1 receptor, were examined in a mouse model of asthma with airway remodelling.
Ovalbumin (OVA) was administered to BALB/c mice, intraperitoneally on days 0 and 14, and intranasally periodically between days 14 and 75.
The mice developed airway eosinophil and mononuclear inflammatory cell infiltration and fibrosis. On day 76, a marked increase in total laminin was seen in the airways of OVA-treated mice compared to controls by Western blot analysis. The increased laminin expression was detected immunocytochemically in the thickened subepithelial basement membrane and around airways and blood vessels. The OVA-treated mice showed increased expression of the
Laminin deposition may be an important component of the airway remodelling observed in chronic allergic lung inflammation and is a process modulated by corticosteroids.
1, ß1, and
1 chains of the laminin-1 isoform in monocytes, macrophages and eosinophils infiltrating the airways. Laminin-1 receptor expression was increased in inflammatory and endothelial cells in the lungs of OVA-treated mice compared to controls. Treatment of OVA-sensitised/challenged mice with dexamethasone reduced airway expression of laminin and laminin-1 receptor in OVA-treated mice but not airway hyperresponsiveness to methacholine.
This article has been cited by other articles:
![]() |
E. H. Walters, D. W. Reid, D. P. Johns, and C. Ward Nonpharmacological and pharmacological interventions to prevent or reduce airway remodelling Eur. Respir. J., September 1, 2007; 30(3): 574 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Lloyd and D. S. Robinson Allergen-induced airway remodelling Eur. Respir. J., May 1, 2007; 29(5): 1020 - 1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hoberg, M. Rudert, T. Pap, G. Klein, S. Gay, and W. K Aicher Attachment to laminin-111 facilitates transforming growth factor {beta}-induced expression of matrix metalloproteinase-3 in synovial fibroblasts Ann Rheum Dis, April 1, 2007; 66(4): 446 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hirano, A. Kanehiro, K. Ono, W. Ito, A. Yoshida, C. Okada, H. Nakashima, Y. Tanimoto, M. Kataoka, E. W. Gelfand, et al. Pirfenidone Modulates Airway Responsiveness, Inflammation, and Remodeling after Repeated Challenge Am. J. Respir. Cell Mol. Biol., September 1, 2006; 35(3): 366 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Henderson Jr., G. K. S. Chiang, Y.-t. Tien, and E. Y. Chi Reversal of Allergen-induced Airway Remodeling by CysLT1 Receptor Blockade Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 718 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miller, J. Y. Cho, K. McElwain, S. McElwain, J. Y. Shim, M. Manni, J. S. Baek, and D. H. Broide Corticosteroids prevent myofibroblast accumulation and airway remodeling in mice Am J Physiol Lung Cell Mol Physiol, January 1, 2006; 290(1): L162 - L169. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. Chu, J. G. Rino, R. B. Wexler, K. Campbell, R. J. Harbeck, and R. J. Martin Mycoplasma pneumoniae infection increases airway collagen deposition in a murine model of allergic airway inflammation Am J Physiol Lung Cell Mol Physiol, July 1, 2005; 289(1): L125 - L133. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Inman Is there a place for anti-remodelling drugs in asthma which may not display immediate clinical efficacy? Eur. Respir. J., July 1, 2004; 24(1): 1 - 2. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |